Revenue, 2025

USD 1881.57 Million

Forecast, 2035

USD 8081.25 Million

CAGR, 2026-2035

15.69%

Report Coverage

China

China Medical Robotics Market Trends For 2026

The China medical robotics market size was estimated at USD 1881.57 million in 2025 and is predicted to increase from USD 2176.79 million in 2026 to approximately USD 8081.25 million by 2035, expanding at a CAGR of 15.69% from 2026 to 2035. Analysis also highlights that the China medical robotics market is rapidly expanding due to increasing robotic systems healthcare applications, growing AI integration, domestic medical-device development, shift towards minimally invasive procedures, and advancements in healthcare infrastructure.

Key Takeaways

• The China medical robotics market will likely exceed USD 2176.79 million by 2026.
• Valuation is projected to hit USD 8081.25 million by 2035.
• Estimated to grow at a CAGR of 15.69% starting from 2026 to 2035.
• By type, the surgical robots segment held a dominant revenue share of 55% of the market in 2025.
• By type, the hospital & pharmacy robots segment held 12% of market share in 2025 and is expected to grow at the fastest CAGR during the forecast period.
• By product type, the equipment segment held a dominant revenue share of 68% of the market in 2025.
• By product type, the instruments & accessories segment held 19% of market share in 2025 and is expected to grow at the fastest CAGR during the forecast period.
• By application type, the clinical segment held a dominant revenue share of 72% of the market in 2025.
• By application type, the pharmacy segment held 11% of market share in 2025 and is expected to grow at the fastest CAGR during the forecast period.
• By setting type, the inpatient segment held a dominant revenue share of 69% of the market in 2025.
• By setting type, the outpatient segment held 17% of market share in 2025 and is expected to grow at the fastest CAGR during the forecast period.
• By end user, the hospitals & clinics segment held a dominant revenue share of 80.37% of the market in 2025.
• By end user, the ambulatory surgical centers segment held 12.85% of market share in 2025 and is expected to grow at the fastest CAGR during the forecast period.

Market Overview 

China's medical robotics refers to the field combining medicine, computer science, and engineering used to assist healthcare professionals in enhancing healthcare delivery across China. They include robotic systems used across surgical procedures, rehabilitation, hospital logistics, pharmacy automation, imaging, radiosurgery, emergency response, patient transportation, and other healthcare applications. Increasing healthcare automation, aging demographics, domestic medical-device development and integration of AI, demand for minimally invasive procedures, imaging and software technologies, and expansion of advanced hospitals are driving the market expansion.

The China medical-device market was valued at US$44.17 billion in 2025 and is anticipated to grow at 9.45%, driven by important market drivers, aging, chronic disease, healthcare infrastructure, AI integration, government support, and domestic manufacturing. Additionally, Towards Healthcare estimates the global robotic surgery market was valued at US$13.79 billion in 2025 and is anticipated to grow at a 16.54% CAGR during the forecast period, where orthopedics is the leading application, and ASC is the fastest-growing end-user category.

Analyst View - Market Size

Chinese medical robotics is among the faster-growing areas of medical technology, with its 15.69% CAGR, which is driven by three overlapping demand pools.

• Clinical robotics: Includes surgical, orthopedic, neurosurgical, urological, and other procedure-specific systems.
• Hospital automation: Encompasses pharmacy, logistics, disinfection, transportation, and telepresence.
• Post-acute and home care: Consisting of rehabilitation robots, exoskeletons, and remote-assistance technologies.

The higher installation rate promotes recurring demand for instruments, accessories, consumables, software, maintenance, training, and integration services, expanding commercial opportunity beyond initial robot-system sales.

Segmental Insights

By Type Insights

Surgical Robots Segment Dominates the Market with 55% share in 2025

As per our research, the table highlights medical robotics types, market share, and CAGR. The surgical robots segment dominated the market with a 55% share in 2025 due to growth in robotic-assisted procedures, broader clinical adoption, and a rise in recurring instrument demand. The hospital & pharmacy robots segment is anticipated to expand rapidly at a 19.40% CAGR during the forecast period due to hospitals automating medication and material workflows, improving dispensing accuracy, and increasing logistics automation.

Analyst View - Type

The surgical robots segment held more than half of the supplied market, which made it a commercial anchor, and its relatively high 17.8% CAGR is also driving its fast growth. On the other hand, the hospital and pharmacy robots segment has the highest CAGR of 19.4%, which opens new opportunities for suppliers that currently depend heavily on capital-intensive surgical platforms. This hierarchy also highlights a transition from robots used exclusively for specialist procedures toward broader hospital automation, such as pharmacy dispensing, logistics, disinfection, and transportation.

Surgical Robotics Subsegment Opportunity

The surgical robotics segment includes a wide range of robots such as laparoscopic surgical robots, orthopedic surgical robots, neurosurgical robots, cardiovascular & vascular robots, gynecological surgical robots, urological surgical robots, dental surgical robots, natural-orifice & endoluminal robots, and percutaneous surgical robots.

Based on Towards Healthcare's global robotic-surgery research, orthopedics, neurology, urology, gynecology, and general surgery are considered the major applications, with orthopedics contributing to the dominant application and general surgery as the high-growth application.

Analyst View - Surgical Robotics

China's opportunity is expanding beyond replicating a single robotic surgery platform to a broader addressable market that includes specialty systems designed around procedure-specific instruments, navigation, imaging, AI-assisted planning, and specialty workflows. Orthopedic and urological applications are particularly relevant to procedure-specific robotics, whereas laparoscopic platforms contribute to a broader procedural base. Furthermore, in the near future, differentiation is likely to shift toward clinical indication coverage, software, instrument ecosystems, surgeon training, and imaging integration.

By Product Insights

Equipment Segment Leads the Market with 68%

Based on the information gathered, the table encompasses product types with their market share and CAGR. The equipment segment led the market with a 68% share in 2025 due to growth in robotic platforms investment by hospitals, enhanced equipment availability by expansion of domestic manufacturing, and a rise in utilization due to new clinical indications. The instruments & accessories segment is expected to show the fastest growth with 18.80% CAGR during the predicted period, due to higher procedure volumes increasing instrument demand, disposable accessories generating recurring revenue, and more robotic procedures expanding accessory consumption.

Analyst View - Product

Medical robots require significant upfront capital expenditure, which contributes to equipment segment dominance, whereas the instruments and accessories segment is expanding at an 18.8% CAGR, creating recurring revenue after system installation.

This produces a two-layer revenue model:

• Initial system sale → procedure expansion → instrument/accessory consumption → software/service → maintenance and upgrades.

Thus, manufacturers capable of launching installed-base models can build recurring revenue streams instead of relying exclusively on new system placements.

By Application Insights

Clinical Segment Held a Dominant Share of 72% of the Market

As per the analysis conducted, the clinical segment held the major market share of 72% in 2025 due to growth in hospital-based robotic-assisted clinical procedures, minimally invasive techniques, which increased system utilization, and expansion of application towards broader indications. The pharmacy segment is anticipated to show the highest growth with 19.70% CAGR during the predicted period as it improves medication workflows, centralizes pharmacy operations, and supports precision and traceability.

Analyst View - Application

The largest revenue base is held by the clinical applications segment, while the stronger growth rates are demonstrated by the pharmacy segment and the hospital operations segment. This is strategically significant because hospital robotics can expand even where hospitals are not ready to invest in complex surgical systems. The repetitive, measurable, and workflow-driven use case makes pharmacy automation particularly attractive. Throughput, accuracy, inventory control, and labor-efficiency metrics can evaluate dispensing, compounding, medication storage, and retrieval. Moreover, hospital/clinical care is identified as the largest application, while home healthcare is among the faster-growing areas as per Towards Healthcare's broader medical-service-robot research.

By Setting Insights

Inpatient Segment Contributed to 69% of Market Share

The given the table highlights medical robotics types, market share, and CAGR. The inpatient segment held the largest share of the market with a 69% share in 2025 as large hospitals remained the primary deployment base, high procedure volumes supported equipment utilization, and tertiary hospitals expanded robotic capabilities. The outpatient segment is expected to show the fastest growth with 18.90% CAGR during the forecast period due to increasing ambulatory procedures, rising demand for compact robotic systems, and hospitals shifting suitable procedures toward day-care settings.

Analyst View - Setting

China's tertiary hospitals can support the surgical teams, infrastructure, and capital investment required for sophisticated robotic systems, which makes the inpatient environment the principal deployment base. Moreover, the outpatient segment's 18.9% CAGR drives a structural shift toward smaller and procedure-specific robotic platforms, while an important expansion pathway, particularly for orthopedic, laparoscopic, and rehabilitation applications, is highlighted by ASCs and specialty clinics.

By End User Insights

Hospitals & Clinics Segment Held Major Revenue Share of 80.37% 

According to the survey conducted, the hospitals & clinics segment led the market with an 80.37% share in 2025 due to high robotic system procurement, expansion of advanced surgical infrastructure, and growth in public and private hospitals' automation investments. The ambulatory surgical centers segment is expected to expand rapidly with an 18.50% CAGR during the upcoming years due to expanding outpatient surgery volumes, ASCs seeking compact high-throughput robotic systems, and shorter stays improving the economics of selected procedures.

Analyst View - End User

More than four-fifths of the supplied market contributes to the hospitals and clinics segment, which confirms that China medical robotics remains primarily an institutional B2B market. Additionally, a slightly higher growth rate than hospitals is reported by the ambulatory surgical centers segment, highlighting a meaningful expansion channel, while robotic rehabilitation moves beyond large hospitals, creating a second growth pathway for rehabilitation centers and home-health.

China Healthcare Technology TAM

The table covers the China medical robotics TAM framework. It represents that the China medical devices market contributed the highest US$; the China smart healthcare market is anticipated to demonstrate high US$ growth; the China AI in healthcare market is expected to expand rapidly with the highest CAGR, while the global robotic surgery market is predicted to show significant growth.

Analyst View – TAM

The intersection of medical devices + smart healthcare + AI + robotics is considered the broadest opportunity instead of medical robotics alone. A technology tailwind for remote monitoring, intelligent workflow management, and robots incorporating computer vision, navigation, and AI-assisted planning is provided by the high growth of China's AI-healthcare market.

SAM - Serviceable Available Market

Based on the information gathered by our multidisciplinary strategist, Aman Singh, the table reflects that surgical robotics contributes to the largest market opportunities, while hospital & pharmacy automation accounts for the high growth opportunities.

Analyst View - SAM

Surgical robots, rehabilitation robots, and hospital/pharmacy automation should be prioritized by the practical SAM instead of considering every emerging robotic technology as equally commercial. The direct clinical needs are addressed by the first two categories, whereas a separate purchasing case based on labor productivity, medication accuracy, and workflow efficiency is provided in hospital automation.

SOM - Serviceable Obtainable Market

The table illustrates the priority institutional deployment base. It covers different types of hospitals and specialty centers utilizing medical robotics for a wide range of applications.

Analyst View - SOM

The most realistic initial obtainable market consists of major academic medical centers, specialty hospitals, and tertiary hospitals in China's major healthcare clusters, along with ASCs and specialized rehabilitation centers. Therefore, deployment strategy should prioritize hospitals that already possess high procedure volumes, advanced imaging infrastructure, specialist surgical teams, robotic-training programs, capital-equipment procurement capability, and established digital hospital infrastructure.

Consumer Behavior

The above-mentioned table focuses on factors influencing consumer behavior, their evidence, and market implications. Moreover, Towards Healthcare identifies minimally invasive procedures, reduced blood loss, pain, scarring, and recovery time as factors supporting robotic surgery adoption.

Analyst View - Consumer Behavior

The medical robots are not purchased directly by patient, instead are influenced by the procedure-selection process. On the other hand, hospitals, surgeons, and payers control the actual purchasing decision. The strongest patient-facing value propositions include minimally invasive treatment, precision, recovery time, reduced procedural trauma, and access to advanced treatment, which in turn makes clinical evidence and physician communication particularly important for adoption.

Buyer Intelligence

The given table highlights buyer intelligence factors, their evidence, and market implications. The high system cost, maintenance, training, and operating expenses are important restraints on robotic-surgery adoption, as per Towards Healthcare.

Analyst View - Buyer Intelligence

A shift from robot acquisition price toward total cost of ownership is anticipated in the hospital procurement decision. Thus, hospitals evaluating a system need to consider capital cost + installation + training + maintenance + instruments + consumables + software + operating-room utilization + procedure volume + clinical outcomes, making installed-base economics critical. Furthermore, the need for expensive consumables, weak service coverage, or limited procedure compatibility makes lower-priced systems less attractive.

Regulatory & Policy Environment

To optimize whole-life-cycle regulation and support innovative development of high-end medical devices, including medical robots, new measures were introduced by China's National Medical Products Administration (NMPA) in July 2025, according to Towards Healthcare reports. Moreover, structural market drivers such as government investment, favorable policies, and domestic manufacturing were also outlined in the China medical-device market research.

Analyst View - Regulatory Environment

Regulation acts as both a barrier and competitive differentiator. The NMPA registration, clinical evidence generation, software validation, cybersecurity, functional safety, robotic-system reliability, instrument traceability, post-market surveillance, and local technical support are important capabilities for manufacturers. China's emphasis on development of high-end domestic medical technologies provides benefits to domestic manufacturers, while established clinical evidence, global installed bases, and advanced technology drive competition among foreign suppliers.

AI, Imaging & Software Intelligence

As per Towards Healthcare analysis, China's AI-healthcare market accounted for US$2.67 billion in 2025 and is projected to expand at a 41.20% CAGR during the predicted period. On the other hand, China's broader smart-healthcare market was valued at US$33.59 billion in 2025 and is projected to expand significantly by 2035. Furthermore, the relevant robotic applications include computer vision, image-guided surgery, automated surgical planning, anatomical recognition, robotic navigation, motion prediction, surgical simulation, remote assistance, predictive maintenance, workflow automation, and intelligent pharmacy systems.

Analyst View - AI & Software

AI is anticipated to become a technology layer across medical robotics, instead of a separate robotic category. The effective AI integration with sensors, imaging, robotic controls, and clinical workflows will drive its commercial value, as well as provide additional recurring-revenue opportunities by analytics and AI-enabled modules, software subscriptions, and upgrades.

Competitive Intelligence

The global surgical robotics companies, Chinese medical-device manufacturers, rehabilitation-robot developers and hospital-automation suppliers are covered in this competitive landscape. Intuitive Surgical, Smith+Nephew, Medrobotics, TransEnterix, Renishaw, Stryker, THINK Surgical, Zimmer Biomet, Medtronic, and CMR Surgical are the companies identified in the global robotic-surgery research of Towards Healthcare. Similarly, based on medical-service-robot research of Towards Healthcare, additional companies such as Ekso Bionics, Hocoma, Cyberdyne, ReWalk Robotics, ABB Robotics, Aethon, Diligent Robotics, Kinova, Savioke, and OhmniLabs contribute to the market growth.

Competitive Structure

Based on our research, the table highlights competitive layers along with their major capabilities.  It confirms that with the growing use of robotics, the procedure precision, treatment delivery, diagnostics, and other healthcare workflows can be improved, promoting market expansion.

Analyst View - Competitive Landscape

Therefore, considering the above-mentioned data, it is highlighted that competition is likely to become increasingly ecosystem-based rather than system-based, while additional revenue can be generated through instruments, accessories, software, training, and service contracts by manufacturers with a strong installed base. Moreover, competitive differentiation for Chinese suppliers can originate from lower total cost of ownership, localization, domestic service networks, procedure-specific systems, NMPA expertise, integration with Chinese hospital infrastructure, and AI/software capabilities. Additionally, the major purchasing considerations such as clinical evidence, installed base, specialized instruments, and surgeon familiarity provide advantages to the global suppliers.

Hospital Procurement & ROI Framework

Table 12: The given table outlines robotic-system purchase evaluation. It covers procurement factors along with the questions raised by the hospitals. The questions revolve around the cost associated with the factors, their specifications, and workflow efficiency.

Analyst View – Procurement

The lowest equipment price will not necessarily be the strongest commercial proposition. Economic value across the complete system lifecycle is essential to be demonstrated by the suppliers. Higher utilization rates are driven by a system with multi-specialty capability, whereas stronger clinical differentiation can be provided by procedure-specific robots. Thus, pricing and sales strategy should be decided according to hospital size, procedure volume, and specialty mix by the vendors.

Hospital & Pharmacy Robotics Opportunity

Only 12% of the supplied market is held by the hospitals & pharmacy robots, but 19.4% CAGR makes them the highest among the major type categories. They provide a wide range of applications across pharmacy, logistics, and hospital operations. For pharmacy, they provide pharmacy dispensing robots, medication compounding robots, and medication storage/retrieval; for logistics, they focus on autonomous hospital delivery, material transportation, medication delivery, and internal supply-chain automation; while for hospital operations, they offer disinfection, telepresence, patient transportation, and critical-care assistance. The hospital logistics, medication delivery, disinfection, telepresence, and patient-care robotics are recorded as important applications by Towards Healthcare's medical-service-robot research, while labor shortages and workflow efficiency are anticipated to support their adoption.

Analyst View - Hospital Automation

As the ROI can be measured through labor hours, delivery time, medication accuracy, inventory efficiency, and infection-control workflows, hospital automation provides a potentially easier deployment pathway compared to complex surgical robotics, as well as creates opportunities for vendors unable to compete directly in capital-intensive surgical robotics.

Rehabilitation Robotics Opportunity

The rehabilitation segment captured 20% of the supplied market and is predicted to expand at 16.90% CAGR. The key subsegments propelling its expansion include lower-limb rehabilitation robots, upper-limb rehabilitation robots, gait-training robots, exoskeletons, and assistive rehabilitation robots. Furthermore, Towards Healthcare's medical-service-robot research also highlighted that more than 2.4 billion people globally live with a health condition which require rehabilation, while shortages of healthcare professionals act as a potential driver for rehabilitation robotics.

Analyst View - Rehabilitation

A bridge between hospital robotics and home healthcare is offered by rehabilitation robotics, where they can be initially deployed in specialist neurological and orthopedic rehabilitation centers and later migrated toward home-based therapy. Products demonstrating measurable improvements in therapy repetition, gait training, range of motion, treatment consistency, therapist productivity, and patient engagement are expected to experience the strongest growth opportunities.

Research & Development Opportunity

The research segment accounted for 7% of applications and is anticipated to grow at 15.80% CAGR during the predicted period. It includes applications such as medical robotics research, surgical simulation, robotic R&D, university research, and institute research. Additionally, research institutions are strategically important because they can act as technology-development and clinical-validation partners.

Analyst View - R&D

Commercialization through collaboration among universities, hospitals, and medical-device companies can be supported by China's research ecosystem. Moreover, research partnerships offer access to surgeons, clinical data, simulation environments and validation infrastructure, which help in reducing the gap between prototype robotics and clinically deployable systems.

Major Market Drivers

As per the survey conducted, the table encompasses market drivers and their impact. The chronic disease, healthcare infrastructure, AI, government policies, aging, and domestic manufacturing are considered among the principal drivers of China's broader medical-device market by Towards Healthcare.

Market Constraints

The above-mentioned table covers various market constraints and their potential impact. Based on the information gathered by Towards Healthcare, high equipment and maintenance costs, training requirements, operational costs, complex implementation, and cybersecurity are the major challenges within medical-service robotics and robotic surgery.

Strategic Market Key Takeaways

Our expert business strategist, Aditi Shivarkar, conducted detailed market research, analyzed company data, clinical trends, and industry developments. Based on her comprehensive analysis, the following strategic key takeaways highlight the most important market insights and opportunities. 

For Service Providers & CDMOs 

• Invest in surgical robots.
• Support the development of imaging robotics.
• Focus on the development of rehabilitation robots.

For Pharma & Biotech Companies 

• Focus on developing laparoscopic surgical robots.
• Collaborate to develop emergency response and hospital robots.
• Support the adoption of pharmacy dispensing robots.

For Investors & Corporate Strategy Teams 

• Invest in hospital & pharmacy robots and remote assistance robotics.
• Support healthcare automation.
• Keep track of evolving regulations.

Expert Insights

Based on the assessment, the market is expanding significantly due to rapid healthcare digitalization. The growth in AI integration and adoption of software technologies are also expected to expand innovations. The new collaboration among the major companies can enhance access to their services and accelerate the development of new specialty robots. The strong growth in hospital & pharmacy robots and rehabilitation robots are also expected to create new market opportunities.

Our Experts

Payal Rabde, Senior Research Analyst, led the primary market research, developed the methodology, analysed trends, segmentation, competition, forecasts, and strategic opportunities, forming the report's analytical foundation. 

Aman Singh, a multidisciplinary strategist, was responsible for collecting and validating clinical trial data, research publications, company information, partnerships, and other quantitative datasets, strengthening evidence-based analysis and market estimations. 

Aditi Shivarkar, an expert business strategist, reviewed the complete research document, performed quality checks, validated findings, refined content, corrected inconsistencies, and finalized the report, ensuring accuracy, clarity, credibility, and publication-ready quality.

Complete Market Segmentation Listing

By Type

• Surgical Robots
  • Laparoscopic Surgical Robots
  • Orthopedic Surgical Robots
  • Neurosurgical Robots
  • Cardiovascular & Vascular Robots
  • Gynecological Surgical Robots
  • Urological Surgical Robots
  • Dental Surgical Robots
  • Natural-Orifice & Endoluminal Robots
  • Percutaneous Surgical Robots
• Rehabilitation Robots
  • Lower-Limb Rehabilitation Robots
  • Upper-Limb Rehabilitation Robots
  • Gait Training Robots
  • Exoskeletons
  • Assistive Rehabilitation Robots
• Hospital & Pharmacy Robots
  • Pharmacy Dispensing Robots
  • Medication Compounding Robots
  • Logistics & Delivery Robots
  • Disinfection & Sanitation Robots
  • Telepresence Robots
• Non-Invasive Radiosurgery Robots
  • Stereotactic Radiosurgery Systems
  • Robotic Radiation Positioning Systems
• Imaging Robots
  • Robotic Imaging Systems
  • Robotic Ultrasound Systems
  • Robotic Endoscopy Systems
• Emergency Response Robotic Systems
  • Emergency Transport Robots
  • Critical-Care Assistance Robots
• Medical Transportation & Handling Robots
  • Patient Transportation Robots
  • Material Handling Robots
  • Autonomous Hospital Delivery Robots
• Other Medical Robots
  • Assistive Robots
  • Telemedicine Robots
  • Micro & Nanorobotic Systems

By Product

• Equipment
  • Robotic Systems
  • Robotic Platforms
  • Robotic Consoles
  • Patient & Surgical Carts
• Instruments & Accessories
  • Surgical Instruments
  • Robotic End Effectors
  • Sensors
  • Vision Systems
  • Disposable Accessories
• Consumables
  • Robotic Surgical Consumables
  • Procedure-Specific Accessories
  • Disposable Instrument Kits
• Services
  • Installation & Integration
  • Maintenance & Technical Support
  • Training & Education
  • Software & Remote Support

By Application

• Clinical
  • Surgery
  • Rehabilitation 
  • Diagnostics & Imaging
  • Radiation Therapy
  • Patient Assistance
• Pharmacy
  • Drug Dispensing
  • Drug Compounding
  • Medication Storage & Retrieval
• Research
  • Medical Research
  • Surgical Simulation
  • Robotic R&D
  • University & Institute Research
• Hospital Operations
  • Logistics
  • Disinfection
  • Telepresence
  • Patient Transportation

By Setting

• Inpatient
  • General Hospitals
  • Tertiary Hospitals
  • Specialty Hospitals
• Outpatient
  • Ambulatory Surgical Centers
  • Outpatient Clinics
  • Specialty Clinics
• Home Care
  • Home Rehabilitation
  • Elderly Care
  • Remote Patient Assistance
• Research & Academic
  • Universities
  • Research Institutes
  • Medical Simulation Centers

By End User

• Hospitals & Clinics
  • Public Hospitals
  • Private Hospitals
  • Tertiary Hospitals
  • Specialty Hospitals
• Ambulatory Surgical Centers
  • Multi-Specialty ASCs
  • Specialty ASCs
• Rehabilitation Centers
  • Neurological Rehabilitation Centers
  • Orthopedic Rehabilitation Centers
  • Geriatric Rehabilitation Centers
• Pharmacies
  • Hospital Pharmacies
  • Centralized Pharmacy Centers
  • Retail & Specialty Pharmacies
• Research Institutes & Laboratories
  • Universities
  • Government Research Institutes
  • Private R&D Centers
• Specialty Centers
  • Cancer Centers
  • Neuroscience Centers
  • Cardiovascular Centers
  • Orthopedic Centers
• Other End Users
  • Long-Term Care Facilities
  • Home Healthcare Providers
  • Emergency Care Facilities